Virtual Patent Marking Notice under 35 U.S.C. § 287(a)
This page is intended to serve as notice under the virtual patent marking provisions of 35 U.S.C. § 287(a), as amended by the America Invents Act. The products and services of Ultrasound AI, Inc. identified below are protected by one or more of the United States patents listed on this page. Additional patents may be pending in the United States and in other jurisdictions. This list may not be all-inclusive, and other Ultrasound AI products not listed here may also be protected by one or more patents.
Delivery Date AI™ (DDAI) and related Ultrasound AI software, systems and services are protected by one or more of the following United States patents:
| U.S. Patent No. | Title |
|---|---|
| 11,266,376 | Premature birth prediction |
| 11,969,289 | Premature birth prediction |
| 12,318,249 | Premature birth prediction |
| 12,369,883 | Artificial intelligence system for determining clinical values through medical imaging |
| 12,721,589 | Artificial intelligence system for determining drug use through medical imaging |
Additional United States patent applications are pending and/or allowed, and additional international patent applications are pending, including before the European Patent Office and the China National Intellectual Property Administration.
Ultrasound AI technology is also protected by patents granted in other jurisdictions, including Israel (IL 298790), Singapore (SG 11202260793S), Japan (JP 7,733,922) and the Republic of Korea (KR 10-2949543).
This page is updated periodically as patents issue and applications are filed. Last updated: September 3, 2026.
Questions regarding Ultrasound AI’s patents may be directed to connect@ultrasound.ai.
